Details Basic Details Status Ongoing Last Updated Friday, December 20, 2024 Original Posting Date Tuesday, January 17, 2023 Health Outcome(s) acute myocardial infarction, deep vein thrombosis, pulmonary embolism, stroke Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR No Result(s) (1) Characterization of Dispensing Patterns of Baricitinib, Ritlecitinib, and Upadacitinib in Patients with Alopecia, Crohn's Disease, Ulcerative Colitis, and Inflammatory Bowel Disease: A Descriptive Analysis Regulatory Link(s) (1) Supplement Approval Letter